| Income Statement |
| Total Revenue | 176.10M |
|
| Revenues (USD) | 176.10M |
| Cost of Revenue | 126.20M |
| Gross Profit | 49.90M |
| Operating Expenses | 39.50M |
| Research and Development Expense | 10.80M |
| Selling, General and Administrative Expense | 26.20M |
| Operating Income | 10.40M |
| Interest Expense | 4.20M |
| Income Tax Expense | 4.80M |
| Net Income | 16.80M |
| Net Income Common Stock | 16.80M |
| Net Income Common Stock (USD) | 16.80M |
| Consolidated Income | 16.80M |
| Earnings per Basic Share | 0.85 |
| Earnings per Basic Share (USD) | 0.85 |
| Earnings per Diluted Share | 0.77 |
| Earning Before Interest & Taxes (EBIT) | 25.80M |
| Earning Before Interest & Taxes (USD) | 25.80M |
| Weighted Average Shares | 19.88M |
| Weighted Average Shares Diluted | 21.89M |
| Balance Sheet |
| Cash and Equivalents | 1.87B |
| Cash and Equivalents (USD) | 1.87B |
| Trade and Non-Trade Receivables | 25.60M |
| Current Assets | 2.32B |
| Property, Plant & Equipment Net | 142.50M |
| Total Assets | 2.53B |
| Total Debt | 1.18B |
| Current Liabilities | 429.50M |
| Debt Non-Current | 1.18B |
| Total Liabilities | 1.69B |
| Accumulated Retained Earnings (Deficit) | 28.30M |
| Accumulated Other Comprehensive Income | -800.00K |
| Shareholders Equity | 845.40M |
| Shareholders Equity (USD) | 845.40M |
| Assets Non-Current | 213.90M |
| Total Debt (USD) | 1.18B |
| Deferred Revenue | 85.00M |
| Goodwill and Intangible Assets | 16.90M |
| Inventory | 377.10M |
| Liabilities Non-Current | 1.26B |
| Trade and Non-Trade Payables | 74.00M |
| Tax Assets | 15.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.90M |
| Net Cash Flow from Financing | 53.80M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 700.00K |
| Capital Expenditure | -71.60M |
| Issuance (Purchase) of Equity Shares | 53.90M |
| Net Cash Flow from Investing | -71.60M |
| Net Cash Flow from Operations | 18.40M |
| Effect of Exchange Rate Changes on Cash | 100.00K |
| Share Based Compensation | 17.70M |